Biotech Hangout cover image

Episode 61

Biotech Hangout

00:00

TIA's Offer to Buy a Company for Less Than Cash

A TIA said they offer undervalued the company at 575 share, which was a 56% premium. The board turned down an offer for I think it was like $7 or $8 a share in cash to bid for like $17 a share on the balance sheet. Josh: What do you think about investors bidding to acquire companies for less than cash? Is that good or is that bad for the industry?

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app